Follow the people · Insider

AH

Arnold C. Hanish

Insider · Director · DCOY

Arnold C. Hanish files insider transactions with the SEC as a director of Decoy Therapeutics (DCOY). We hold 3 disclosed purchases and sales filed since 24 January 2006, 2 of them in the last 90 days.

  • Files forDCOY
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure2 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 31 August 202631 August 2026Director · Decoy Therapeutics (DCOY)1 Form 4 line · source: SEC Form 4
  • Filed 26 September 201227 August 2026Director · Omeros (OMER)31 Form 4 lines · source: SEC Form 4
  • Filed 10 September 201930 December 2025Director · Salarius Pharmaceuticals (SLRX)21 Form 4 lines · source: SEC Form 4
  • Filed 20 January 200629 August 2012Chief Accounting Officer · Lilly Eli & Co (LLY)27 Form 4 lines · source: SEC Form 4

Everything they disclosed

80 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.